GPCR

Structure Therapeutics Inc. - American Depositary Shares (GPCR)

About Structure Therapeutics Inc. - American Depositary Shares (GPCR)

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Details

Daily high

$36.99

Daily low

$35.00

Price at open

$35.34

52 Week High

$94.90

52 Week Low

$23.59

Market cap

2.5B

Dividend yield

Volume

1.0M

Avg. volume

1.1M

P/E ratio

-11.36

Structure Therapeutics Inc. - American Depositary Shares News